- Home
- UEIC vs SONN Comparison
UEIC vs SONN Comparison
Compare UEIC & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UEIC | SONN |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.9M | 32.4M |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | UEIC | SONN |
|---|---|---|
| Price | $3.23 | $3.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $9.25 | ★ $20.00 |
| AVG Volume (30 Days) | 148.9K | ★ 781.7K |
| Earning Date | 11-06-2025 | 12-16-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $390,997,000.00 | $1,000,000.00 |
| Revenue This Year | $0.57 | $5,376.22 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 2.35 | ★ 1689.52 |
| 52 Week Low | $2.69 | $1.08 |
| 52 Week High | $12.50 | $19.30 |
Technical Indicators
Market Signals| Indicator | UEIC | SONN |
|---|---|---|
| Relative Strength Index (RSI) | 43.13 | 37.81 |
| Support Level | $3.06 | $3.56 |
| Resistance Level | $3.36 | $4.25 |
| Average True Range (ATR) | 0.19 | 0.85 |
| MACD | 0.08 | -0.16 |
| Stochastic Oscillator | 75.70 | 1.08 |
Price Performance
Historical ComparisonAbout UEIC Universal Electronics Inc.
Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.